Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Tax drag in dividend ETFs can shave after-tax gains. This quick primer explains the concept and practical implications for investors.
13,081 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
March has delivered a mixed bag for investors as oil swings, AI news, and private credit worries collide. This guide ...
A wave of new positions from hedge funds loading boeing points to a cautious but growing bet that Boeing can rebound ...
Israel launched airstrikes on Iran’s nuclear facilities, drawing Iran’s vow of retaliation and sending tremors throug...
Tech giants drive a broad market surge as AI earnings power gains push the Nasdaq toward a nasdaq defy gravity record...
Many investors chase headline names, but a quiet stock nobody's talking about could surge as AI, data, and systems de...
How did xplr (xifr) perform in Q1 2026, and what does it mean for 2026 earnings guidance? This article breaks down th...
Visa and Mastercard lead the global payments world, forming a true duopoly. This article breaks down which stock off...
As the Q1 2026 earnings transcript approaches, investors look for how Millicom will balance growth across mobile serv...
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
Dell Technologies rides a booming AI infrastructure cycle into 2027, with a record AI backlog and ambitious revenue t...
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...